Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID‐19

The broad immunomodulatory properties of human mesenchymal stem cells (MSCs) have allowed for wide application in regenerative medicine as well as immune/inflammatory diseases, including unmatched allogeneic use. The novel coronavirus disease COVID‐19 has unleashed a pandemic in record time accompan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, B. Linju, Yen, Men‐Luh, Wang, Li‐Tzu, Liu, Ko‐Jiunn, Sytwu, Huey‐Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Concise Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300965/
https://www.ncbi.nlm.nih.gov/pubmed/32526079
http://dx.doi.org/10.1002/sctm.20-0186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300965/
https://www.ncbi.nlm.nih.gov/pubmed/32526079
http://dx.doi.org/10.1002/sctm.20-0186

Ejemplares similares